KALA BIO, Inc. Made Headway
Wed, Nov 26, 2025 at 07:46 PM
KALA BIO, Inc. (KALA:NASDAQ) rocketted at $0.91, representing a gain of 42.6%. On Wed, Nov 26, 2025, KALA:NASDAQ hit a New 2-Week High of $0.91. The stock got featured on our News Catalysts scanner on Thu, Nov 13, 2025 at 02:31 AM in the 'INVESTOR UPDATE' category. From Wed, Nov 12, 2025, the stock recorded 40.00% Up Days and 27.27% Green Days
About KALA BIO, Inc. (KALA:NASDAQ)
Kala Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary nanoparticle-based Mucus Penetrating Particles technology, with focus on the treatment of eye diseases.
Top 10 Gainers:
- SMX (Security Matters) Public Limited Company (SMX:NASDAQ), 194.42%
- Pasithea Therapeutics Corp. (KTTA:NASDAQ), 117.39%
- Amber International Holding Limited (AMBR:NASDAQ), 56.33%
- KALA BIO, Inc. (KALA:NASDAQ), 42.63%
- Quantum BioPharma Ltd. (QNTM:NASDAQ), 41.92%
- Mobile-health Network Solutions (MNDR:NASDAQ), 39.47%
- Verrica Pharmaceuticals Inc. (VRCA:NASDAQ), 31.05%
- K Wave Media Ltd. (KWM:NASDAQ), 29.59%
- Boqii Holding Limited (BQ:NYSEMKT), 29.55%
- Quince Therapeutics, Inc. (QNCX:NASDAQ), 29.21%